Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Disponible en: Askarpour M, Hadi A, Miraghajani M, Symonds ME, Sheikhi A, Ghaedi E
doi: 10.1016/j.postharvbio.2013.12.017 132
Initially, GLP-1s were developed to treat type 2 diabetes and were marketed for that purpose under brand names such as Ozempic (semaglutide), Rybelsus (semaglutide), Victoza (liraglutide), and Mounjaro (tirzepatide)
The medication works by mimicking the GLP-1 hormone, which slows gastric emptying, reduces appetite, and promotes weight loss
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6
PMID 8598105.
US$ 27.26
US$ 28.91
US$ 23.73
US$ 27.59
US$ 21.33
US$ 22.78
